Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains.-Reference-Cited by-同舟云学术

Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domains.

Published:1988-01 Issue:2 Volume:263 Page:1023-1029
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Larsen G R,Henson K,Blue Y

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference25 articles.

1. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.

2. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

3. The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.

4. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator

5. Autonomous functions of structural domains on human tissue-type plasminogen activator.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial;Stroke;2024-02

2. Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial;Stroke and Vascular Neurology;2024-01-29

3. Reteplase Fc-fusions produced in N. benthamiana are able to dissolve blood clots ex vivo;PLOS ONE;2021-11-30

4. Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion;Molecular Biology Reports;2019-11-01

5. The fibrinolytic factor tPA drives LRP1‐mediated melanoma growth and metastasis;The FASEB Journal;2018-11-20